O99.32
Drug use complicating pregnancy, childbirth, and the puerperium
Clinical Classification Guidelines
Use Additional Code
- code(s) from F11-F16 and F18-F19 to identify manifestations of the drug use
Medical Intelligence & Overview
ICD-10 Code O99.32 refers to complications arising from drug use during pregnancy, childbirth, and the postpartum period (puerperium). This classification covers cases where substance use impacts maternal health and fetal development, posing additional risks during this critical time. Recognizing and understanding this condition helps in providing appropriate care and support for pregnant women struggling with substance use and ensuring healthier outcomes for both mother and baby.
Causes & Symptoms
Clinical Causes: Use of illegal drugs such as cocaine, heroin, or methamphetamine during pregnancy Misuse or abuse of prescription medications, including opioids, benzodiazepines, or stimulants Inadequate treatment or management of existing substance use disorders Lack of access to addiction treatment programs or prenatal care Psychological factors leading to continued drug use during pregnancy
Key Symptoms: Signs of drug intoxication or withdrawal in the mother Complications such as preterm labor or miscarriage Fetal growth restriction or low birth weight Signs of neonatal abstinence syndrome (NAS) in the newborn, including irritability, tremors, poor feeding, or vomiting Increased risk of placental abruption or placenta previa Maternal health issues such as hypertension or infections related to substance use
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of maternal history, screening for substance use, and laboratory testing. Healthcare providers may use urine, blood, or hair tests to detect recent or ongoing drug use. Medical assessments also include monitoring fetal well-being through ultrasounds and other evaluations to detect any growth or development issues. Confirming the diagnosis is essential for guiding appropriate interventions and support.
Treatment Protocols: Comprehensive prenatal care with close monitoring of maternal and fetal health Counseling and behavioral therapies to support substance cessation and prevent relapse Medication-assisted treatment (MAT) for opioid dependence, such as methadone or buprenorphine Management of complications like hypertension, infections, or other pregnancy-related issues Providing education and support to the mother about substance use and pregnancy risks Postpartum support for continued substance abstinence and mental health care
Clinical Advice & FAQs
Billing Guidance
Is O99.32 a billable ICD-10 code?
Yes, O99.32 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O99.32?
Clinical documentation must specify the nature of Drug use complicating pregnancy, childbirth, and the puerperium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference